Ausgabe 1/2012
Inhalt (21 Artikel)
Biological therapy and the immune system in patients with chronic myeloid leukemia
Peter Rohon
Mycophenolate mofetil: fully utilizing its benefits for GvHD prophylaxis
Kentaro Minagawa, Motohiro Yamamori, Yoshio Katayama, Toshimitsu Matsui
Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care
Roberto Stasi, Magaral Murali, Marc Michel, Jean-François Viallard, Aristoteles Giagounidis, Ann Janssens, Jason Legg, Robert Deuson, Mark D. Danese
Diagnosis of acquired bone marrow failure syndrome during childhood using the 2008 World Health Organization classification system
Wenyu Yang, Peihong Zhang, Asahito Hama, Masafumi Ito, Seiji Kojima, Xiaofan Zhu
Molecular analysis of afibrinogenemic mutations caused by a homozygous FGA1238 bp deletion, and a compound heterozygous FGA1238 bp deletion and novel FGA c.54+3A>C substitution
Yuka Takezawa, Fumiko Terasawa, Kazuyuki Matsuda, Mitsutoshi Sugano, Aiko Tanaka, Mitsuhiro Fujiwara, Keigo Kainuma, Nobuo Okumura
Comprehensive therapeutic outcomes of frontline imatinib mesylate in newly diagnosed chronic phase chronic myeloid leukemia patients in Korea: feasibility assessment of current ELN recommendation
Dongho Kim, Hyun Gyung Goh, Soo-Hyun Kim, Soo-Young Choi, Sa-Hee Park, Eun-Jung Jang, Dong-Wook Kim
High serum carbohydrate antigen-125 (CA-125) level predicts poor outcome in patients with follicular lymphoma independently of the FLIPI score
Vít Procházka, Edgar Faber, Luděk Raida, Zuzana Kapitáňová, Kateřina Langová, Karel Indrák, Tomáš Papajík
Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia
Hui Yang, Hui Liang, Jing-song Yan, Rong Tao, Si-guo Hao, Li-yuan Ma
Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low–intermediate risk, aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508
Yoshitoyo Kagami, Kuniaki Itoh, Kensei Tobinai, Haruhiko Fukuda, Kiyoshi Mukai, Takaaki Chou, Chikara Mikuni, Tomohiro Kinoshita, Noriyasu Fukushima, Yoshio Kiyama, Takayo Suzuki, Tsuneo Sasaki, Yuko Watanabe, Kunihiro Tsukasaki, Tomomitsu Hotta, Masanori Shimoyama, Michinori Ogura
Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study
Atsushi Wakita, Shigeki Ohtake, Satoru Takada, Fumiharu Yagasaki, Hirokazu Komatsu, Yasushi Miyazaki, Kohmei Kubo, Yukihiko Kimura, Akihiro Takeshita, Yoko Adachi, Hitoshi Kiyoi, Takuhiro Yamaguchi, Minoru Yoshida, Kazunori Ohnishi, Shuichi Miyawaki, Tomoki Naoe, Ryuzo Ueda, Ryuzo Ohno
Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
Katsuto Takenaka, Koji Nagafuji, Ken Takase, Tomohiko Kamimura, Yasuo Mori, Yoshikiyo Ito, Yukiko Nishi, Hideho Henzan, Koji Kato, Naoki Harada, Tetsuya Eto, Toshihiro Miyamoto, Takanori Teshima, Koichi Akashi
Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients
Kazuhiro Ikegame, Katsuji Kaida, Satoshi Yoshihara, Masayuki Fujiwara, Kyoko Taniguchi, Ruri Kato, Takayuki Inoue, Tatsuya Fujioka, Hiroya Tamaki, Masaya Okada, Toshihiro Soma, Norihiko Kamikonya, Hiroh Saji, Shozo Hirota, Hiroyasu Ogawa
Characteristics and influencing factors of CD19+ B cell reconstitution in patients following haploidentical/mismatched hematopoietic stem cell transplantation
Min Xie, Hai-Xia Fu, Ying-Jun Chang, Lan-Ping Xu, Dai-Hong Liu, Xiao-Hui Zhang, Wei Han, Kai-Yan Liu, Xiao-Jun Huang
Rituximab in a child with autoimmune thrombotic thrombocytopenic purpura refractory to plasma exchange
Parameswaran Narayanan, Aparna Jayaraman, Rashi S. Rustagi, S. Mahadevan, Sreejith Parameswaran
Light chain deposition disease affecting the gastrointestinal tract in the setting of post-living donor kidney transplantation
Victor H. Jimenez-Zepeda, Rajkumar Vajpeyi, Rohan John, Suzanne Trudel
Elevation of pulmonary artery pressure as a complication of nilotinib therapy for chronic myeloid leukemia
Dariusz Zakrzewski, Ilona Seferynska, Krzysztof Warzocha, Tomasz Hryniewiecki
Acute myeloid leukemia with mediastinal myeloid sarcoma refractory to acute myeloid leukemia therapy but responsive to l-asparaginase
Hiroyoshi Takahashi, Katsuyoshi Koh, Motohiro Kato, Hiroshi Kishimoto, Eiji Oguma, Ryoji Hanada
Splenic infarction, warm autoimmune hemolytic anemia and antiphospholipid antibodies associated with systemic lupus erythematosus
Irfan Yavasoglu, Gurhan Kadikoylu, Zahit Bolaman
Clinical relevance of the association of interferon alfa to imatinib in chronic myeloid leukemia therapy
Fabio Stagno, Paolo Vigneri, Francesco Di Raimondo
On the prevalence and genetic predisposition of monoclonal gammopathy of undetermined significance (MGUS)
Guillermo J. Ruiz-Argüelles, Guillermo J. Ruiz-Delgado
Efficacy of pleural biopsy for diagnosis of pleural effusion due to chronic GVHD after hematopoietic stem cell transplantation
Masashi Miyauchi, Akihide Yoshimi, Yasuhito Nannya, Yutaka Takazawa, Motoshi Ichikawa, Masashi Fukayama, Mineo Kurokawa